propionylcarnitine has been researched along with Arterial Obstructive Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (63.64) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiatt, WR | 1 |
| Andreozzi, P; Cangemi, R; Loffredo, L; Meloni, V; Panico, MA; Pignatelli, P; Violi, F | 1 |
| Izzo, A; Koverech, A; Liguori, M; Messano, M; Palermo, G; Riccioni, C; Sarcinella, R; Virmani, A | 1 |
| Amato, B; Aprea, G; Cerfolio, P; Markabaoui, AK; Persico, G | 1 |
| Azzena, G; Cittanti, C; Colamussi, P; Giganti, M; Manfrini, S; Orlandi, C; Piffanelli, A; Uccelli, L | 1 |
| Brogden, RN; Wiseman, LR | 1 |
| Dal Lago, A; De Martini, D; Flore, R; Gaetani, E; Gasbarrini, A; Gerardino, L; Nolfe, G; Pola, R; Santoliquido, A; Serricchio, M; Tondi, P | 1 |
| Barone, G; Costanza, G; Di Salvo, A; Marchese, G; Verruso, G; Zamueli, M | 1 |
| Luca, S; Terranova, R | 1 |
| Berardi, E; Brevetti, G; Godi, L; Perna, S; Rossini, A; Sabbà, C; Scotto di Uccio, V | 1 |
| Coto, V; D'Alessandro, L; Grattarola, G; Imparato, L; Lingetti, M; Mancini, M; Nolfe, G; Rengo, F | 1 |
2 review(s) available for propionylcarnitine and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Carnitine and peripheral arterial disease.
Topics: Arterial Occlusive Diseases; Carnitine; Humans; Intermittent Claudication; Muscle, Skeletal; Oxygen Consumption | 2004 |
Propionyl-L-carnitine.
Topics: Aged; Arterial Occlusive Diseases; Cardiotonic Agents; Carnitine; Clinical Trials as Topic; Humans; Muscle, Skeletal | 1998 |
8 trial(s) available for propionylcarnitine and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Imbalance between nitric oxide generation and oxidative stress in patients with peripheral arterial disease: effect of an antioxidant treatment.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arterial Occlusive Diseases; Carnitine; Cross-Sectional Studies; Deoxyguanosine; Female; Humans; Male; Middle Aged; Nitric Oxide; Oxidative Stress | 2006 |
Evaluation of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic patients affected by obliterating arteriopathy Leriche stage II.
Topics: Aged; Arterial Occlusive Diseases; Cardiovascular Agents; Carnitine; Combined Modality Therapy; Diabetes Mellitus, Type 2; Female; Humans; Infusions, Intravenous; Intermittent Claudication; Intermittent Pneumatic Compression Devices; Male; Middle Aged; Quality of Life; Recovery of Function; Severity of Illness Index; Time Factors; Treatment Outcome; Walking | 2008 |
The early effects of intravenous L-propionyl carnitine on ulcerative trophic lesions of the lower limbs in arteriopathic patients: a controlled randomized study.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Anti-Inflammatory Agents, Non-Steroidal; Arterial Occlusive Diseases; Blood Coagulation; Carnitine; Female; Humans; Infusions, Intravenous; Ketoprofen; Leg Ulcer; Male; Middle Aged; Peripheral Vascular Diseases; Regional Blood Flow | 1995 |
Technetium-99m sestamibi leg scintigraphy for non-invasive assessment of propionyl-L-carnitine induced changes in skeletal muscle metabolism.
Topics: Arterial Occlusive Diseases; Carnitine; Female; Humans; Leg; Male; Middle Aged; Muscle, Skeletal; Peripheral Vascular Diseases; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Ultrasonography, Doppler | 1997 |
Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial.
Topics: Adult; Aged; Arterial Occlusive Diseases; Cardiotonic Agents; Carnitine; Double-Blind Method; Exercise Test; Female; Humans; Intermittent Claudication; Leg; Male; Middle Aged; Placebos | 1999 |
[Comparison between L-propionyl carnitine and physical-rehabilitative exercise in diabetics with obliterative arteriopathy of the legs (Fontaine's stage IIa)].
Topics: Arterial Occlusive Diseases; Cardiotonic Agents; Carnitine; Diabetic Angiopathies; Female; Humans; Leg; Male; Middle Aged | 1999 |
Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous, double-blind, cross-over study.
Topics: Arterial Occlusive Diseases; Carnitine; Dose-Response Relationship, Drug; Double-Blind Method; Exercise Test; Hemodynamics; Humans; Infusions, Intravenous; Intermittent Claudication; Ischemia; Leg; Male; Middle Aged | 1992 |
Evaluation of the therapeutic efficacy and tolerability of levocarnitine propionyl in the treatment of chronic obstructive arteriopathies of the lower extremities: a multicentre controlled study vs. placebo.
Topics: Administration, Oral; Aged; Analysis of Variance; Arterial Occlusive Diseases; Arteriosclerosis; Carnitine; Diabetic Angiopathies; Female; Humans; Intermittent Claudication; Male; Middle Aged; Patient Compliance; Regression Analysis; Stereoisomerism | 1992 |
1 other study(ies) available for propionylcarnitine and Arterial Obstructive Diseases
| Article | Year |
|---|---|
[Treatment of chronic arterial occlusive disease of the lower limbs with propionyl-1-carnitine in elderly patients].
Topics: Aged; Arterial Occlusive Diseases; Cardiotonic Agents; Carnitine; Chronic Disease; Female; Humans; Leg; Male; Middle Aged | 2001 |